NCT04695782
Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy
Recruiting · Phase 2 · University of Aarhus · registry updated 2021-01-05
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.
Inclusion
- Locally recurrent rectal cancer.
- Bioptically verified (adenocarcinoma )
- Available dose plan from primary radiotherapy
- Previous pelvic RT (\>30Gy EQD2)
- Evaluated in MDT-conferences (Herlev, Aarhus)
- Age\>18 years
Exclusion
- Non-resectable distant metastases (PET-CT)
- Unable to undergo MRI, PET-CT
- Inability to attend full course radiotherapy and follow up in the out patient clinic.